Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06891833 |
| Consolidated Lead Sponsor | Sichuan Baili Pharmaceutical Co |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II/III |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 985 participants (ESTIMATED) |
| Registered Start Date | 2025-06-05 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Anhui Provincial Cancer Hospital | Hefei, China | Open Hospital Dossier -> |
| The First Affiliated Hospital of Chongqing Medical University | Chongqing, China | Open Hospital Dossier -> |
| Fujian Medical University Union Hospital | Fuzhou, China | Open Hospital Dossier -> |
| Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University | Guangzhou, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.